Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. (COCP) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · COCP · as of Sep 30, 2025
Ownership Breakdown
21
Institutional Holders
$831,250
Total Inst. Value
▼ $191,678 vs Q2
10.25M
Shares Outstanding
freeFloat 66.06%
664,983
13F Shares Held
▼ 21,533 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
COCP largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC pharmaceutical preparations | 268.1K | 2.63% | 2.63% | $335.10M | Nov 7, 2025 | — held |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 127.9K | 1.26% | 1.26% | $159.91M | Nov 13, 2025 | ▲ 2.9K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 73.9K | 72.66% | 72.66% | $92.43M | Nov 12, 2025 | ▲ 829 |
BLACKROCK, INC. pharmaceutical preparations | 73.7K | 72.48% | 72.48% | $92.18M | Nov 12, 2025 | — held |
NEUBERGER BERMAN GROUP LLC pharmaceutical preparations | 31.9K | 31.34% | 31.34% | $39.86M | Nov 12, 2025 | ▲ 31.9K |
JANE STREET GROUP, LLC pharmaceutical preparations | 21.0K | 20.68% | 20.68% | $26.30M | Nov 14, 2025 | NEW |
STATE STREET CORP pharmaceutical preparations | 20.5K | 20.19% | 20.19% | $25.68M | Nov 14, 2025 | — held |
PARALLEL ADVISORS, LLC pharmaceutical preparations | 12.6K | 12.40% | 12.40% | $15.76M | Nov 13, 2025 | ▼ 2.6K |
NORTHERN TRUST CORP pharmaceutical preparations | 11.9K | 11.72% | 11.72% | $14.90M | Nov 14, 2025 | — held |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 9.1K | 8.94% | 8.94% | $11.37M | Feb 3, 2026 | ▼ 9 |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
4
Increased
+35.6K shares3
New Positions
first time holders4
Decreased
−24.3K shares4
Sold Out
fully exitedNet shares change (top 50)
+11.3K
+35.6K / −24.3K
Net new holders
-1
3 new / 4 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
COCP insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
FROST PHILLIP MD ET AL
| Feb 24, 2026 | Purchase | 20,000 | $1.00 | $20.0K | 1.91M | Form 4 ↗ |
FROST PHILLIP MD ET AL
| Feb 6, 2026 | Purchase | 50,000 | $0.95 | $47.3K | 1.89M | Form 4 ↗ |
Kornberg Roger D. director | Jan 9, 2026 | Award | 24,615 | $1.10 | $27.1K | 24.6K | Form 4 ↗ |
PFENNIGER RICHARD C JR director | Jan 9, 2026 | Award | 16,410 | $1.10 | $18.1K | 16.4K | Form 4 ↗ |
Lee Sam President and Co-CEO | Jan 9, 2026 | Award | 49,229 | $1.10 | $54.2K | 49.2K | Form 4 ↗ |
Hassan Fred director | Jan 9, 2026 | Award | 16,410 | $1.10 | $18.1K | 16.4K | Form 4 ↗ |
Martin James Joseph Co-CEO and CFO | Jan 9, 2026 | Award | 49,229 | $1.10 | $54.2K | 49.2K | Form 4 ↗ |
FROST PHILLIP MD ET AL
| Jan 9, 2026 | Award | 24,615 | $1.10 | $27.1K | 24.6K | Form 4 ↗ |
Japour Anthony J director | Jan 9, 2026 | Award | 16,410 | $1.10 | $18.1K | 16.4K | Form 4 ↗ |
Rubin Steven D director | Jan 9, 2026 | Award | 16,410 | $1.10 | $18.1K | 16.4K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Cocrystal Pharma, Inc. (COCP) is primarily owned by institutional investors, who hold approximately 6.5% of total shares outstanding. Company insiders own approximately 33.94%, while retail and public investors account for the remaining 59.57%.
The largest institutional shareholder of Cocrystal Pharma, Inc. is VANGUARD GROUP INC, holding approximately 268,080 shares — equal to 2.63% of outstanding shares — as of September 30, 2025.
A total of 21 institutional investors currently hold COCP stock, with a combined institutional value of approximately $831,250 as of the most recent 13F filing period.
Frequently asked questions
COCP ownershipCocrystal Pharma, Inc. (COCP) is primarily owned by institutional investors, who hold approximately 6.5% of shares. The largest shareholder is VANGUARD GROUP INC with a 2.63% stake. Company insiders hold 33.94%. Data sourced from SEC Form 13F as of September 30, 2025.